Steven Ryder

Chief Medical Officer, Rallybio.

Companies

Yarrow Bioscience, Inc.Chief Medical Officer Jul 29, 2026 to now¹
MBX Biosciences, Inc.Board member Sep 12, 2024 to now²
RallybioChief Medical Officer Jul 29, 2021 to Feb 19, 2025³
REATA PHARMACEUTICALS INCBoard member Jul 11, 2022 to Sep 26, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

REATA PHARMACEUTICALS INC0 shares⁵Sep 26, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 26, 2023Returned to company 10,907 shares of REATA PHARMACEUTICALS INC⁵
Jun 7, 2023Granted 1,682 shares at $93.61 of REATA PHARMACEUTICALS INC⁶
Jun 7, 2023Granted 347 shares at $93.61 of REATA PHARMACEUTICALS INC⁶
Jul 11, 2022Granted 3,794 shares at $32.36 of REATA PHARMACEUTICALS INC⁷
Jul 11, 2022Granted 4,171 shares at $32.36 of REATA PHARMACEUTICALS INC⁷
Jul 11, 2022Granted 913 shares at $32.36 of REATA PHARMACEUTICALS INC⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARYarrow Bioscience, Inc., Chief Medical Officer
2
SEC EDGARMBX Biosciences, Inc., Board member
3
SEC EDGARRallybio, Chief Medical Officer
4
SEC EDGARREATA PHARMACEUTICALS INC, Board member
5
SEC EDGARREATA PHARMACEUTICALS INC shares after the filing of Sep 26, 2023
6
SEC EDGARForm 4 filed Jun 9, 2023
7
SEC EDGARForm 4 filed Jul 12, 2022